Mary L Keohan Selected Research

Mary L Keohan Research Topics

10	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 12/2003
8	Neoplasms (Cancer) 01/2022 - 05/2005
4	Hemangiosarcoma (Angiosarcoma) 01/2022 - 07/2009
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 10/2019
3	Synovial Sarcoma (Synovioma) 10/2020 - 07/2009
3	Leiomyosarcoma 01/2019 - 07/2009
3	Neurofibrosarcoma (MPNST) 01/2019 - 07/2009
2	Aggressive Fibromatosis (Desmoid) 01/2022 - 05/2010
2	Hypophosphatemia 01/2022 - 01/2022
2	Anemia 01/2022 - 01/2022
2	Fibroma (Fibromatosis) 01/2022 - 05/2010
2	Exanthema (Rash) 01/2022 - 01/2022
2	Liposarcoma 09/2009 - 07/2009
1	Edema (Dropsy) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Fever (Fevers) 01/2019
1	Fatigue 11/2015
1	Hoarseness 11/2015
1	Hypertension (High Blood Pressure) 11/2015
1	Histiocytic Sarcoma 11/2015
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Giant Cell Tumor of Bone 07/2009
1	Solitary Fibrous Tumors 07/2009
1	Fibrosarcoma 07/2009
1	Malignant Fibrous Histiocytoma 07/2009
1	Rhabdomyosarcoma 07/2009
1	Malignant Mesothelioma 05/2005
1	Hemorrhagic Cystitis 12/2003

4	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2009
3	Immune Checkpoint InhibitorsIBA 03/2022 - 04/2014
3	binimetinibIBA 01/2022 - 10/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 11/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2009
2	Docetaxel (Taxotere)FDA Link 11/2015 - 01/2015
2	Gemcitabine FDA Link 11/2015 - 01/2015
2	AnthracyclinesIBA 05/2010 - 09/2009
2	Ifosfamide FDA LinkGeneric 09/2009 - 12/2003
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	CreatinineIBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	pexidartinibIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 11/2015
1	pazopanib FDA Link 11/2015
1	Bevacizumab (Avastin)FDA Link 01/2015
1	poly ICLCIBA 04/2014
1	resiquimodIBA 04/2014
1	Toll-Like Receptor AgonistsIBA 04/2014
1	AntigensIBA 04/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2014
1	Monoclonal AntibodiesIBA 04/2014
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2010
1	TrabectedinIBA 09/2009
1	Phosphotransferases (Kinase)IBA 07/2009
1	Sunitinib (Sutent)FDA Link 07/2009
1	N 30IBA 07/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2006
1	Mesna (Coenzyme M)FDA LinkGeneric 12/2003